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ABSTRACT
Background: Laparoscopic sleeve gastrectomy (LSG)
has emerged as an alternative restrictive bariatric pro-
cedure to the most popular laparoscopic adjustable
gastric banding (LAGB). We analyze and compare the
clinical and weight loss outcomes of LSG versus LAGB
for the treatment of severe obesity in high-risk patients.
Methods: Forty severely obese veterans (20/group)
received either LSG or LAGB and were followed pro-
spectively for 2 years. Outcome measures included op-
erating room (OR) time, estimated blood loss (EBL),
length of hospital stay (LOS), morbidity, mortality, re-
operations, readmission rates, and weight loss over
time.
Results: The cohort primarily comprised high-risk and
older male veterans. Patient’s baseline demographics
were similar between groups. LSG was associated with
prolonged OR time (11631 vs. 9428min), higher EBL
(3428 vs. 1719mL), and LOS (2.9 vs. 1.4days)
when compared with LAGB. Minor morbidity and read-
missions were similar between groups, while no major
morbidity, reoperations, or mortality occurred. Total
weight and BMI decreased significantly after surgery in
both groups (LSG: 30252 to 237lbs and 455t o
365kg/m
2 vs. LAGB: 28036 to 23129lbs and 435
to 365kg/m
2, respectively). Total weight loss was su-
perior in the LSG vs. LAGB group at 2 years
(TWL6524 vs. 4928 lbs (P.03); %EWL5120
vs. 4623%; %EBMI loss4822 vs. 4523%, and
%BWL 218 vs. 179%, respectively).
Conclusion: In severely obese and high-risk patients,
laparoscopic sleeve gastrectomy provides superior total
weight loss at 2 years.
Key Words: Laparoscopic sleeve gastrectomy, Laparo-
scopic adjustable gastric banding, Severe obesity, Out-
comes, Weight loss.
INTRODUCTION
Bariatric surgery is the only effective long-term treatment
available for severe obesity that effectively decreases both
morbidity and mortality.1 Roux-Y gastric bypass has been
performed for decades, and is the most common bariatric
procedure performed in the United States today. How-
ever, Roux-Y gastric bypass has been associated with
multiple long-term complications. Most recently, restric-
tive only procedures, such as laparoscopic adjustable gas-
tric banding, have been developed and appear to be
related to lower morbidity and mortality. The long-term
outcomes associated with the gastric banding procedure
have been dissatisfying. Nevertheless, its safety profile has
been shown to be better than that of Roux-Y gastric
bypass.2,3
Laparoscopic sleeve gastrectomy is a modification of
the Magenstrasse and Mill operation that has emerged
as an alternative restrictive bariatric procedure to the
most popular laparoscopic adjustable gastric banding.
Laparoscopic sleeve gastrectomy has not been widely
accepted by the Center for Medicare & Medicaid Service
(CMS) and few insurance carriers. Therefore, US trials
involving this procedure are limited and yet to be pub-
lished.
The purpose of this clinical trial was to prospectively
analyze and compare the perioperative clinical and
weight loss outcomes of laparoscopic sleeve gastrec-
tomy vs. laparoscopic adjustable gastric banding for the
treatment of severe obesity in high-risk patients.
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SCIENTIFIC PAPERMATERIALS AND METHODS
Study Design
A single-institution, prospective equivalency clinical
trial was conducted. Patients recruited to participate in
this clinical trial underwent surgical procedures and
were followed up at the Dallas Veterans Affairs Bariatric
Surgery Program for a mean of 2 years. This study was
granted Institutional Review Board approval and was
registered with the NIH with identifier NCT00434655.
Written informed consent was obtained at the time of
the first encounter. The purpose of this clinical trial was
to compare the short-term clinical and weight loss out-
comes of 2 restrictive bariatric procedures, laparoscopic
sleeve gastrectomy and laparoscopic adjustable gastric
banding, for the treatment of severe obesity. We hy-
pothesized that laparoscopic sleeve gastrectomy pro-
vides comparable short-term (2-year) clinical and
weight loss outcomes to those of laparoscopic adjust-
able gastric banding for the treatment of severe obesity
in high-risk patients. We specifically aimed to establish
differences in perioperative clinical outcomes between
groups and to establish differences in weight loss over
time between treatment groups. Patient’s inclusion and
exclusion study entry criteria are shown in Table 1.
Participating subjects underwent bariatric surgery over
a span of an 18-month period as described below.
Bariatric surgeons with expertise in both procedures
performed the surgical procedures.
Treatment Groups
Laparoscopic Sleeve Gastrectomy
Laparoscopic sleeve gastrectomy was performed by a
5-port approach. The gastrocolic ligament was divided
with bipolar cautery (LigaSure Vessel Sealing System, Val-
leylab, Boulder, CO). The greater curvature of the stom-
ach and the fundus were mobilized. A 32-French blunt
bougie was placed transorally and advanced to the pylo-
rus. The sleeve gastrectomy was created by multiple ap-
plications of a 60-mm stapler with 4.1-mm staple loads
(Echelon 60 Endopath Stapler and Cutter, Ethicon Endo-
Surgery, Cincinnati, OH) and staple-line reinforcement
(Seamguard, Bioabsorbable Staple Line Reinforcement,
W.L Gore and Associate Inc. Flagstaff, AZ), which ex-
tended approximately 6cm to 7cm from the pylorus to-
ward the angle of His, creating a gastric tube with approx-
imately 40cc to 50cc of volume. An intraoperative
gastroscopy was performed to evaluate the integrity of the
staple line and to perform an air leak test. The stomach
specimen was extracted through an extended left upper
quadrant trocar site.
Laparoscopic Adjustable Gastric Banding
Laparoscopic adjustable gastric banding was performed
with 5 abdominal ports. A retro-gastric window was cre-
ated bluntly by the standard “pars flaccida” technique. A
10-mL AP Standard (APS) LapBand (Allergan Inc, Irvine,
CA) was primed on the back table with approximately
3mL of saline solution and inserted into the abdomen,
placed below the gastroesophageal junction and buckled
Table 1.
Study Patient Selection Criteria
Inclusion criteria:
1. Adult (18 y/o) severely obese patients who meet 1991 NIH consensus criteria for obesity surgery (ie, BMI35 with
comorbidities or BMI40mg/kg
2).
2. Patients who have given written informed consent for the study. Their chosen procedure was included in 1 of 2 study groups.
Exclusion criteria:
1. Patients who have contraindications prohibiting general anesthesia.
2. Pregnancy.
3. Previous bariatric, gastric, or upper abdominal procedures, except cholecystectomy.
4. Uncontrollable medical conditions.
5. Uncontrollable psychiatric conditions.
6. Presence of a known large ventral or hiatal hernia.
7. Elderly 65 y/o.
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trogastric stitches were placed to secure the band in place.
The band tubing was exited and connected to the access
port. Saline solution was allowed to exit the tubing until
the intraband pressure was equalized with the atmo-
spheric pressure. After this, the access port was implanted
subcutaneously and secured to the rectus abdominis fas-
cia with interrupted and nonabsorbable sutures.
Patient Care and Follow-up
Patients underwent routine postoperative care in the post-
anesthesia care unit (PACU) and transferred to the surgery
ward. A Gastrografin upper gastrointestinal contrast study
was obtained on postoperative day#1i na l lpatients.
Liquid diet was initiated after a normal contrast study was
confirmed. Patients were discharged home after they
demonstrated that they were ambulatory, tolerating a liq-
uid diet, and achieving incisional pain control with oral
narcotics. All participating subjects were followed up 2
weeks after surgery and subsequently on a monthly basis
for the first 12 months and every 3 months thereafter for
the duration of the study. For the gastric banding group,
adjustment sequence was performed at the office until
adequate gastric band restriction or the “green zone” was
achieved (ie, adequate weight loss, food portion control,
minimal postprandial appetite, no reflux, or dysphagia
symptoms, and patient’s satisfaction) by adding between
1mL and 4mL of saline solution.
Outcome Measures
The main outcome measure for this trial was mean total
weight loss (TWL) over time. Weight loss was also ex-
pressed as the percentage of excess weight loss (%EWL),
percentage of excess of body mass index (BMI) loss
(%EBMIL), and percentage of the initial body weight loss
(%BWL) over time. The percentage of EWL was calculated
as the ratio between excess weight over the ideal body
weight (IBW) and postoperative TWL. BMI was estimated
as the ratio between weight and height squared. The IBW
was obtained according to the published medium size
data from the Metropolitan Life Tables. Secondary out-
come measures included mean operative time, estimated
blood loss, length of hospital stay (LOS), hospital read-
missions, reoperation rates, minor and major morbidity,
and mortality. Minor morbidity was defined as that one
not requiring reoperation or any other invasive or endo-
scopic intervention or extensive hospital resource utiliza-
tion. Major morbidity was defined as the one requiring
any of the above interventions. Operative time was ob-
tained from the time of the first skin incision until the last
wound was closed.
Power Analysis
A total of 40 subjects were required for this equivalency
clinical trial (20 per group). An equivalence test of weight
loss means using 2 one-sided tests on data from a parallel-
group design with sample sizes of 20 in the gastric band-
ing group and 20 in the sleeve gastrectomy group
achieved 84% power (beta0.16) at a 5% significance
level when the true difference between the weight loss
means is 0.00, the standard deviation is 10.00, and the
equivalence weight loss limits are -10.00 and 10.00 lbs.
Power analysis was performed using 2008 PASS software
(NCSS, Kaysville, UT).
Statistical Analysis
Demographic, clinical, weight loss, and quality of life data
were recorded and stored in a secured prospectively col-
lected bariatric surgery database. Outcome data were
compared between groups. Differences between group
means were determined by 2-sample Student t test. Dif-
ferences between group proportions were established by
2-sample Z-test. A P-value .05 was considered statisti-
cally significant. Statistical analysis was performed with
the 12.0 SPSS statistical software (SPSS, Chicago, IL).
RESULTS
Demographic Data
Mean age, sex, and race/ethnicity distributions were com-
parable between bariatric surgery groups (Table 2). Pre-
operative mean height, weight, and BMI were similar in
both groups. There were no differences in American So-
ciety of Anesthesiologists (ASA) scores. The majority of
patients fell in the high-risk category: ASA scores 3,
mean age 50 years, and male sex.
Clinical Outcome Data
In the sleeve gastrectomy group, the mean operative room
time and estimated blood loss were significantly higher
compared to that with gastric banding. The sleeve gastrec-
tomy group’s length of hospital stay doubled that of gas-
tric banding. Minor morbidity was similar between proce-
dures (Table 3). There were no major complications,
mortality, or reoperations in either group. Readmissions
were similar between treatments (one in each arm).
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Overall morbidity and procedure-related complications
were comparable between groups (Table 4). Morbidity in
the gastric banding group was related to an overfilled
band causing postoperative food intolerance that resolved
with band deflation. One sleeve gastrectomy patient was
readmitted for intravenous hydration due to poor oral
intake and dehydration. A second sleeve gastrectomy pa-
tient developed tape allergy with blistering that resolved
with local therapy, and a third patient had postoperative
uncontrolled diabetes that required intravenous insulin
therapy in the ICU. There was one wound cellulitis epi-
sode in each group that did not require wound reopening
and resolved with oral antibiotics.
Weight Loss Data
Total weight and BMI decreased significantly after sur-
gery in both groups at 2 years (LSG: 30252 to 237lb
and 455t o3 6 5kg/m
2 vs. LAGB: 28036 to 23129lb
and 435t o3 6 5kg/m
2, respectively; Table 5). Weight
loss was equivalent at 12 months: TWL6724 vs.
5228lb; %EWL5220 vs. 4723%; %EBMI
loss4922 vs. 4623% and %BWL 228 vs. 199%,
respectively. However, total weight loss was superior in
the LSG group at 24 months (TWL6524 vs. 4928lb
(P0.03); %EWL5120 vs. 4623%; %EBMI
loss4822 vs. 4523% and %BWL 218 vs. 179%,
respectively).
DISCUSSION
In the present severely obese and high-risk cohort, we
demonstrated that laparoscopic adjustable gastric banding
Table 2.
Preoperative Patient’s Characteristics
Variables
a LSG
a LAGB
a
Mean age (years) 51.78 54.98
Male sex (%) 60.0 80.0
Race/ethnicity (%)
Caucasians 75.0 60.0
Blacks 15.0 35.0
Hispanics 10.0 5.0
Mean height (inches) 68.84 68.53
Mean weight (lb) 30252 28036
Mean ideal body weight (lb) 21839 21326
Mean BMI (kg/m
2) 44.85 42.55
ASA score 3 (%) 75 75
aBMIbody mass index; ASAAmerican Society of Anesthesiolo-
gists; LSGlaparoscopic sleeve gastrectomy; LAGBlaparoscopic
adjustable gastric band.
Table 3.
Perioperative Clinical Outcomes Data
Variables
a LSG
a (meanSD) LAGB
a (meanSD)
OR time (minutes) 115.631 93.928
b
EBL (mL) 33.828 16.619
b
ICU utilization (%) 35.0 25.0
Mean LOS (days) 2.4.9 1.2.4
b
Overall morbidity (%) 20.0 10.0
Mortality (%) 0 0
aLSGlaparoscopic sleeve gastrectomy; LAGBLaparoscopic
adjustable gastric band; EBLestimated blood loss; ICUintense
care unit; LOSlength of stay.
bP.05 vs. LSG by t test.
Table 4.
Short-term Morbidity Data
Variable LSG
a LAGB
a
Minor Morbidity (%) 20.0 10.0
— Wound cellulitis 5.0 5.0
— Tape allergy 5.0 0
— Nausea/vomiting 5.0 5.0
— Uncontrolled DM
a 5.0 0
Major Morbidity 0 0
Readmissions 5.0 5.0
Reoperations 0 0
aDMDiabetes Mellitus; LSGlaparoscopic sleeve gastrectomy;
LAGBlaparoscopic adjustable gastric band.
Table 5.
Two-year Weight Loss Data
Weight Loss
a LSG
a (MeanSD) LAGB
a (MeanSD)
TWL (lb) 6524 4928*
EWL (%) 5120 4623
EBMI (%) 4822 4523
BWL (%) 2181 7 9
aLSGlaparoscopic sleeve gastrectomy; LAGBlaparoscopic ad-
justable gastric band; TWLtotal weight loss; EWLexcess weight
loss; EBMILexcess of body mass index loss; BWLinitial body-
weight lost.
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effective procedures for the treatment of severe obesity.
Both approaches are associated with low short-term mor-
bidity and readmission rates with no reoperations or mor-
tality. However, laparoscopic sleeve gastrectomy provides
superior total weight loss at 2 years.
Prospective randomized trials have shown favorable out-
comes with the use of laparoscopic over open bariatric
surgical techniques.4–7 Therefore, bariatric surgery has
shifted to predominantly laparoscopic approaches. In the
US, the most common laparoscopic bariatric surgery has
been Roux-Y gastric bypass. Unfortunately, this procedure
has been associated with various long-term complications
and may not be most suitable for high-risk and older
populations.
In a recent perioperative safety longitudinal bariatric sur-
gery study, bariatric surgery was found to be a very safe
procedure with mortality rates close to those of hip re-
placement or cholecystectomy.8 This large cohort study
showed that severely obese patients who underwent lapa-
roscopic gastric bypass had a higher risk of adverse events
compared to those who underwent laparoscopic adjust-
able gastric banding.
Laparoscopic restrictive procedures, particularly adjust-
able gastric banding, has been shown to have an im-
proved safety profile compared to gastric bypass.2,3 There-
fore, this restrictive only procedure became very popular
after its FDA approval in 2001. Most recently, laparoscopic
sleeve gastrectomy emerged as an alternative primary
procedure to the popular gastric banding for the treatment
of severe obesity. Sleeve gastrectomy is currently not
widely available, because it is has not been approved as a
covered benefit by the CMS. Its implementation is limited
to select high-risk individuals and bariatric centers as a
first stage of a 2-staged procedure.9 This translates into
lack of evidence-based data where the number of US trials
is insufficient. Not long ago, the American Association of
Metabolic and Bariatric Surgery released a revised state-
ment identifying laparoscopic sleeve gastrectomy as a
suitable option for select severely obese individuals.10
There also has been concern among bariatric surgeons
regarding the sleeve gastrectomy safety profile and sus-
tained weight loss over time.
Although, laparoscopic gastric banding and sleeve gas-
trectomy are both considered restrictive operations, sur-
gical techniques, postoperative care, and weight loss
mechanistic pathways vary widely. In addition, sleeve
gastrectomy is perceived as a more invasive procedure
because at least two-thirds of the stomach is removed.
Gastric banding produces adjustable restriction to food
and appetite reduction by unclear mechanisms, while
sleeve gastrectomy induces weight loss by ghrelin elimi-
nation, rapid gastric emptying, and other unknown hor-
monal mediated mechanisms with almost complete appe-
tite suppression.11 Compared to the gold standard
operation, laparoscopic Roux-Y gastric bypass, both lapa-
roscopic restrictive procedures are indeed less complex
and demanding.
There is a substantial number of severely obese among
veterans being cared for at the Veterans Affairs Health
Care System (VAHCS).12 The VAHCS has the highest rate
of severe obesity of any other health care system, with
37% of females and 33% of males being obese. This high
prevalence has increased the number of bariatric surgeries
within the VAHCS. The VAHCS severely obese veterans
who undergo bariatric surgery differ from those at aca-
demic or private sectors, which comprise mostly younger
and low-risk females. Veterans are predominantly older
males with severe systemic diseases and lower socioeco-
nomic background.13 Both laparoscopic gastric banding
and sleeve gastrectomy procedures appear to be tailored
to this severely obese and high-risk veteran population.
Our data support findings of prospective randomized clin-
ical trials by Himpens et al14 comparing gastric banding
and sleeve gastrectomy, where weight loss was superior
for the sleeve group however with a higher number of
complications. Sleeve gastrectomy has also been shown to
provide more than 50% of excess weight loss at 6 years.15
In our study, the total weight loss was greater after sleeve
gastrectomy at 2 years. In addition, there was a general
trend that favored laparoscopic sleeve gastrectomy in
other weight loss parameters. No significant weight loss
differences between the first and second year was ob-
served. This may be likely to an increase in follow-up visit
intervals during the second year. The majority of weight
loss occurred within the first year and stabilized at year 2
with no additional weight loss. The weight loss of the
sleeve gastrectomy and gastric banding groups are similar
to those reported in other studies. These data suggest that
close follow-up may also be essential for sleeve gastrec-
tomy patients, to prevent weight regain or weight loss
failure.
The complication rates between gastric banding and
sleeve gastrectomy groups did not reach statistical signif-
icance in the present study. What is evident is that when
complications occurred, they did not require additional
invasive procedures or extensive hospital resource utili-
zation. On the other hand, no major complications or
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hospital length of stay for the sleeve gastrectomy group
was twice that of the gastric banding group. This was
commonly the result of increased incisional pain at the
sleeve specimen extraction site. Operative times observed
with sleeve gastrectomy were prolonged compared to
operative times for banding. The increased time in this
group was likely associated with additional procedural
steps including gastroscopy, leak testing, and specimen
extraction. Finally, the intraoperative blood loss with gas-
tric banding was significantly lower but perhaps this find-
ing is of no clinical relevance.
This study has several limitations. First, this trial was not
randomized. It proved difficult to randomize subjects to 2
very dissimilar surgical procedures at a medium volume
bariatric program. Second, we analyzed short-term out-
comes only, and follow-up was insufficient to provide
long-term ( 2 years) weight loss comparisons. Lastly, the
study did not provide enough power to allow compari-
sons of resolution of comorbidities.
CONCLUSION
In the context of this severely obese, high-risk, older male
cohort, laparoscopic sleeve gastrectomy was associated
with prolonged operative time, blood loss, and hospital
stay compared with laparoscopic adjustable gastric band-
ing. Both procedures have low short-term minor morbid-
ity and readmission rates with no associated major mor-
bidity, reoperations, or mortality. Both approaches are
safe and effective for the treatment of severe obesity.
However, laparoscopic sleeve gastrectomy offers superior
2-year total weight loss. Long-term prospective random-
ized trials comparing both surgical treatments in large
groups of severely obese and high-risk patients are war-
ranted.
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